| Name: | Enalapril EP Impurity G |
| Catalogue No. | VL1360007 |
| CAS No. | 460720-14-3 |
| Molecular Formula | C₁₅H₂₇NO₄ |
| Molecular Weight | 285.38 |
| Status | In-stock |
| IUPAC Name | (2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]propanoic acid, |
| Appearance | White Powder |
| Description | Enalapril EP Impurity G (CAS No.460720-14-3) or (2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]propanoic acid. Enalapril is a prodrug that is hydrolyzed after absorption to form the active angiotensin-converting enzyme Enalaprilat. It is administered orally. It decreases blood pressure by lowering peripheral resistance without increasing heart rate. It is well tolerated and safe. |
| References | "Davies, Richard O., et al. “Enalapril Worldwide Experience.” The American Journal of Medicine, vol. 77, no. 2, Aug. 1984, pp. 23–35, https://doi.org/10.1016/s0002-9343(84)80055-8. Todd, Peter A., and Karen L. Goa. “Enalapril.” Drugs, vol. 43, no. 3, Mar. 1992, pp. 346–81, https://doi.org/10.2165/00003495-199243030-00005. " |
